CFTR and cystic fibrosis: The latter constitutes a key pathway in the onset and regulation of proinflammatory responses, including those altered in CF, as some studies have reported increased levels of eicosanoids in bronchoalveolar fluid from CF patients [20] and in the supernatant of epithelial cells expressing the F508del mutation of CFTR [21].